Analysts Conflicted on These Healthcare Names: Bristol-Myers Squibb (BMY) and Envista Holdings (NVST)
Express News | Navitas Semiconductor Shares Drop 20.3% Premarket After Q4 Revenue Outlook Below Estimates
Stifel Maintains Envista Holdings(NVST.US) With Buy Rating, Maintains Target Price $24
Envista Holdings Third Quarter 2024 Earnings: Beats Expectations
Envista Holdings Price Target Raised to $17.00/Share From $16.00 by Piper Sandler
Envista Upgraded to Market Perform by Leerink, Management Cited
This Wingstop Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Evercore Maintains Envista Holdings(NVST.US) With Buy Rating, Raises Target Price to $26
Stifel Maintains Envista Holdings(NVST.US) With Buy Rating, Raises Target Price to $24
Needham Reiterates Hold on Envista Holdings
A Quick Look at Today's Ratings for Envista Holdings(NVST.US), With a Forecast Between $19 to $26
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Envista Holdings Is Maintained at Neutral by Baird
Leerink Partners Upgrades Envista Holdings to Market Perform, Raises Price Target to $23
Envista Holdings Analyst Ratings
Express News | Envista Holdings Corp : Piper Sandler Raises Target Price to $17 From $16
Envista Holdings Corporation (NVST) Q3 2024 Earnings Conference Call Transcript Summary
Envista Holdings Corporation (NVST) Q3 2024 Earnings Conference Call Transcript
Express News | Envista Holdings Corp Outlook FY Adjusted Ebitda Margins Between 10% and 12%
Express News | Envista Holdings Corp: FY 2024, Continue to Expect Core Sales Growth of -1% to -4%
No Data
No Data